OTSUKA PHARMACEUTICAL CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public, Subsidiary
- Established
- 1964-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.otsuka.co.jp
Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-11-17
- Last Posted Date
- 2012-08-10
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 316
- Registration Number
- NCT00791999
Efficacy Confirmation Trial of CDP870 Without Coadministration of Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)
- First Posted Date
- 2008-11-17
- Last Posted Date
- 2012-08-07
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 230
- Registration Number
- NCT00791921
Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-10-06
- Last Posted Date
- 2021-03-01
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 1095
- Registration Number
- NCT00766545
A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients
- First Posted Date
- 2008-04-25
- Last Posted Date
- 2014-04-25
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 230
- Registration Number
- NCT00666965
A Multicenter Investigative Study of the Safety and Efficacy of Long-term Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
- First Posted Date
- 2008-02-01
- Last Posted Date
- 2014-03-13
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 41
- Registration Number
- NCT00606229
A Multicenter, Investigative Study of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
- First Posted Date
- 2008-02-01
- Last Posted Date
- 2014-02-12
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 59
- Registration Number
- NCT00606320
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group-comparison Trial of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
- First Posted Date
- 2008-02-01
- Last Posted Date
- 2014-02-12
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 258
- Registration Number
- NCT00606281
A Multicenter, Placebo-controlled, Double-blind Investigative Extension Trial of the Safety and Efficacy of Aripiprazole in the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode
- First Posted Date
- 2008-02-01
- Last Posted Date
- 2014-02-12
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 99
- Registration Number
- NCT00606177
A Study of OPC-41061 in Subjects With Cardiac-induced Edema (Congestive Heart Failure)
- First Posted Date
- 2007-10-16
- Last Posted Date
- 2014-01-30
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 52
- Registration Number
- NCT00544869
A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients
- First Posted Date
- 2007-10-01
- Last Posted Date
- 2014-03-19
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Target Recruit Count
- 180
- Registration Number
- NCT00537485
© Copyright 2024. All Rights Reserved by MedPath